FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileMedtronic plc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
MDT
Medtronic plc Stock AnalysisComprehensive stock analysis for Medtronic plc (MDT) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMDT
MDT
Medtronic plc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
MDT
  1. Home
  2. Stocks
  3. Medtronic plc

Medtronic plc

🇺🇸MDT•NYSE

Medtronic plc

🇺🇸MDT•NYSE
Market cap
$131.60B
Sentiment

Your view on MDT

Mkt Cap
$131.60B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Medtronic plc

Industry
Medical - Devices
Sector
Healthcare
CEO
Geoffrey Straub Martha
Headquarters
20 On Hatch, Galway, IE
Industry
Medical - Devices
Sector
Healthcare
CEO
Geoffrey Straub Martha
Headquarters
20 On Hatch, Galway, IE
Description

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.

Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.

The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease.

Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments.

It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain.

The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Medtronic plc from FRC's valuation model, read against the market price. MDT last traded at $102.88, 25.3× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Medtronic plc. Starting points for Medtronic plc: P/E 25.3, EPS $4.09, beta 0.57 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Medtronic plc. Medtronic plc paid $2.86 per share over the last year — a 2.8% yield at the current $102.88 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Medtronic plc. Trailing twelve-month EPS for Medtronic plc stands at $4.09. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$101.76

average of 17 firms, last 12 months

 

$101.76

Low $83.00

Median $99.00

High $120.00

 

Analyst Ratings

Buy22 firms, last 12 months
  • Strong Buy0
  • Buy16
  • Hold6
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrOct 2026Next QtrJan 2027Current YearFY Apr 2027Next YearFY Apr 2028
Avg. estimate$1.33$1.43$5.98$6.40
Low estimate$1.31$1.41$5.96$6.28
High estimate$1.40$1.45$6.00$6.55
No. of analysts16161717
Year-ago EPS$1.36$1.36$3.73—
Growth-1.9%+4.8%+60.2%—

Revenue Estimate

RevenueCurrent QtrOct 2026Next QtrJan 2027Current YearFY Apr 2027Next YearFY Apr 2028
Avg. estimate$9.48B$9.52B$39.05B$40.28B
Low estimate$9.41B$9.43B$38.82B$36.90B
High estimate$9.55B$9.56B$39.15B$41.02B
No. of analysts15152121
Year-ago revenue$8.96B$9.02B$36.36B—
Growth+5.8%+5.6%+7.4%—
Recent analyst actions15 rating and price-target changes, latest Nov 17, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, Investing; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Medtronic plc. Medtronic plc has reported as a listed company since 1973. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold MDT19 companies · 8 funds
Compare MDT with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • AVRAnteris Technologies Global Corp.Medical - Devices$556M
  • BSXBoston Scientific CorporationMedical - Devices$63.3B
  • EWEdwards Lifesciences CorporationMedical - Devices$61.6B
  • GNGBYGetinge AB (publ)Medical - Devices$6.1B
  • LIVNLivaNova PLCMedical - Devices$5.1B
  • PENPenumbra, Inc.Medical - Devices$12.6B
  • PHGKoninklijke Philips N.V.Medical - Devices$29.3B

More Medical - Devices companies

  • AMBBYAmbu A/SOTC$3.3B
  • AMBFFAmbu A/SOTC$3.7B
  • AMIXAutonomix Medical, Inc. Common StockNASDAQ$597,632
  • AORTArtivion, Inc.NYSE$901M
  • AQQRFAquarius Surgical Technologies Inc.OTC$115,917
  • ARAYAccuray IncorporatedNASDAQ$8M
  • ARMMArmm Inc.OTC$106,246
  • ARX.AXAroa Biosurgery LimitedASX
  • ASAPFAurora Spine CorporationOTC$16M
  • ASG.VAurora Spine CorporationTSXV$16M
  • ASTI.CNAquarius Surgical Technologies Inc.CNQ
  • AT1.AXAtomo Diagnostics LimitedASX

ETFs holding Medtronic plc

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.18%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.16%
  • IVViShares Core SP 500 ETF$852.9B in assets0.20%
  • SPYState Street SPDR S&P 500 ETF Trust$818.5B in assets0.20%
  • IHIiShares US Medical Devices ETF$4.0B in assets11.77%
  • HHL.TOHarvest Healthcare Leaders Income ETF$2.2B in assets4.86%
  • FDLFirst Trust Morningstar Dividend Leaders Index Fund$8.4B in assets2.53%
  • GCOWPacer Global Cash Cows Dividend ETF$3.7B in assets2.37%

Largest holders first, then the funds most concentrated in MDT.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Medtronic plc, and how their positions are changing. At a $131.60B market value, institutional positions materially move Medtronic plc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Medtronic plc executives and directors. Shares of Medtronic plc have traded between $79.29 and $102.48 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Medtronic plc. Medtronic plc is a $131.60B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Medtronic plc. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Medtronic plc. Coverage tracks Medtronic plc within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Medtronic plc.

MDT Analysis
Fair
Past1
Growth4
Health3
Profit2
Value1

News

Latest Market News